Raltegravir Potassium

CAS 871038-72-1 9 current records 2 historicalSmall Molecule

Who holds supplier records for Raltegravir Potassium? 9 organisations hold a current record for Raltegravir Potassium: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 5 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6) and China (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Raltegravir Potassium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/raltegravir-potassium

Reading the evidence

  • 9 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    6 of the 7 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (9)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Raltegravir Potassium. Country is the organisation's recorded country, not necessarily the manufacturing site.

India6China1Country not recorded for 2
  • MATRIX PHARMACORP PRIVATE LTD
    Active DMF 30595, 27728 · latest filing Jun 2016
    IndiaCEP
  • Hetero Drugs Limited
    Active DMF 25261, 37182 · latest filing Dec 2022
    IndiaCEP Company GMP cert on record
  • APICORE LLC (A WHOLLY OWNED SUB OF RK PHARMA INC)
    Active DMF 43235 · latest filing Dec 2025
  • APITORIA PHARMA PRIVATE LTD
    Active DMF 39315 · latest filing Dec 2023
    India Company GMP cert on record
  • LUPIN MANUFACTURING SOLUTIONS LTD
    Active DMF 34206 · latest filing Sept 2019
  • MAITHRI DRUGS PRIVATE LTD
    Active DMF 36083 · latest filing Jun 2021
    India Company GMP cert on record
  • IndiaCEP Company GMP cert on record
  • IndiaCEP Company GMP cert on record
  • Shanghai Desano Chemical Pharmaceutical Co., Ltd
    ChinaCEP
Need Raltegravir Potassium sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (5)

Certificates of Suitability on the EDQM register for Raltegravir Potassium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 6 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
AURORE LIFE SCIENCES PRIVATE LIMITED HyderabadIN
CEP 2026-461 - Rev 00
Raltegravir potassium, Form-1
Nov 2026—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2020-216 - Rev 02
Raltegravir potassium
Sept 2025—
HETERO DRUGS LIMITED HyderabadIN
CEP 2023-193 - Rev 00
Raltegravir potassium, Form III
Jul 2025—
LAURUS LABS LIMITED HyderabadIN
CEP 2023-211 - Rev 00
Raltegravir potassium
Feb 2025—
SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD. Laogang TownCN
CEP 2023-329 - Rev 00
Raltegravir potassium
Dec 2024—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Raltegravir Potassium are no longer active. These show a past filing, not current supply.

Show all 2 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Raltegravir Potassium is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL518520).

Chemical identity

IUPAC name
potassium 4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-2-[2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl]-6-oxopyrimidin-5-olate
Canonical SMILES
CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)[O-])C(=O)NCC3=CC=C(C=C3)F.[K+]
InChIKey
IFUKBHBISRAZTF-UHFFFAOYSA-M
Synonyms
Isentress, Isentress hd, L-000900612 POTASSIUM SALT, L000900612 POTASSIUM SALT, MK-0518, MK-0518 POTASSIUM, MK0518 POTASSIUM, Raltegravir monopotassium salt, Raltegravir potassium, Raltegravir potassium component of dutrebis, Raltegravir potassium salt, DUTREBIS COMPONENT RALTEGRAVIR POTASSIUM

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor
Mechanism of action
HIV Integrase Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Raltegravir Potassium?

9 organisations hold an active US FDA Type II Drug Master File or a CEP for Raltegravir Potassium: MATRIX PHARMACORP PRIVATE LTD (India), Hetero Drugs Limited (India), APICORE LLC (A WHOLLY OWNED SUB OF RK PHARMA INC), APITORIA PHARMA PRIVATE LTD (India), LUPIN MANUFACTURING SOLUTIONS LTD, MAITHRI DRUGS PRIVATE LTD (India), Aurore Life Sciences (India) and Laurus Labs Limited (India), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Raltegravir Potassium Drug Master Files are active?

MATRIX PHARMACORP PRIVATE LTD (DMF 30595, 27728), Hetero Drugs Limited (DMF 25261, 37182), APICORE LLC (A WHOLLY OWNED SUB OF RK PHARMA INC) (DMF 43235), APITORIA PHARMA PRIVATE LTD (DMF 39315), LUPIN MANUFACTURING SOLUTIONS LTD (DMF 34206) and MAITHRI DRUGS PRIVATE LTD (DMF 36083). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Raltegravir Potassium records mean?

2 organisations have only inactive Type II DMFs for Raltegravir Potassium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Raltegravir Potassium have a European Certificate of Suitability?

Yes. 5 organisations hold a valid CEP for Raltegravir Potassium on the EDQM register, including AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), HETERO DRUGS LIMITED Hyderabad (IN), LAURUS LABS LIMITED Hyderabad (IN) and SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD. Laogang Town (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Raltegravir Potassium supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Raltegravir Potassium?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.